Sign in

CIK 0001520262 · Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981007018
Phone
00-353-1-772-8000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,070,874
in 5 filings, $1.1M under 10b5-1 plans

Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hopkinson Craig C. −$423K EVP R&D, Chief Medical Officer sold 12% of stake
  2. Nichols Christian Todd −$373K SVP, Chief Commercial Officer sold 7% of stake
  3. Gaffin David Joseph −$275K EVP, CLO, Alkermes, Inc. sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-17 MCKEON BRIAN P Director Other acquisition · Non Qualified Stock Option (Right to Buy) +231 $30.86 $7K 11,785
2023-11-17 MCKEON BRIAN P Director Other acquisition · Non Qualified Stock Option (Right to Buy) +254 $30.72 $8K 12,986
2023-11-17 MCKEON BRIAN P Director Other acquisition · Restricted Stock Unit Award +119 6,104
2023-11-17 Daglio David Angelo Jr. Director Other acquisition · Non Qualified Stock Option (Right to Buy) +90 $22.48 $2K 4,639
2023-11-17 Daglio David Angelo Jr. Director Other acquisition · Non Qualified Stock Option (Right to Buy) +523 $22.48 $12K 26,692
2023-11-17 Daglio David Angelo Jr. Director Other acquisition · Restricted Stock Unit Award +88 4,533
2023-11-17 Daglio David Angelo Jr. Director Other acquisition · Non Qualified Stock Option (Right to Buy) +313 $24.24 $8K 15,990
2023-11-17 Daglio David Angelo Jr. Director Other acquisition · Non Qualified Stock Option (Right to Buy) +231 $30.86 $7K 11,785
2023-11-17 Daglio David Angelo Jr. Director Other acquisition · Non Qualified Stock Option (Right to Buy) +254 $30.72 $8K 12,986
2023-11-17 Daglio David Angelo Jr. Director Other acquisition · Restricted Stock Unit Award +119 6,104
2023-11-17 Jackson Blair Curtis EVP, Chief Operating Officer Other acquisition · Employee Stock Option (Right to Buy) +599 $46.24 $28K 30,599
2023-11-17 Jackson Blair Curtis EVP, Chief Operating Officer Other acquisition · Employee Stock Option (Right to Buy) +469 $69.83 $33K 23,969
2023-11-17 Jackson Blair Curtis EVP, Chief Operating Officer Other acquisition · Employee Stock Option (Right to Buy) +899 $31.64 $28K 45,899
2023-11-17 Jackson Blair Curtis EVP, Chief Operating Officer Other acquisition · Employee Stock Option (Right to Buy) +699 $53.50 $37K 35,699
2023-11-17 Jackson Blair Curtis EVP, Chief Operating Officer Other acquisition · Employee Stock Option (Right to Buy) +759 $65.94 $50K 38,759
2023-11-17 Jackson Blair Curtis EVP, Chief Operating Officer Other acquisition · Employee Stock Option (Right to Buy) +1,489 $31.93 $48K 75,989
2023-11-17 Jackson Blair Curtis EVP, Chief Operating Officer Other acquisition · Employee Stock Option (Right to Buy) +1,534 $20.03 $31K 78,287
2023-11-17 Jackson Blair Curtis EVP, Chief Operating Officer Other acquisition · Restricted Stock Unit Award +91 4,680
2023-11-17 Jackson Blair Curtis EVP, Chief Operating Officer Other acquisition · Employee Stock Option (Right to Buy) +3,102 $19.34 $60K 158,221
2023-11-17 Jackson Blair Curtis EVP, Chief Operating Officer Other acquisition · Restricted Stock Unit Award +380 19,387

Page 35 of 41 · 804 trades